Liver Injury/Regeneration News

Visceral adipose tissue with low liver fat increased the risk for a coronary heart disease event, according to a presenter at The Liver Meeting Digital Experience.

Investigators observed higher rates of morbidity and mortality in patients with chronic liver disease with COVID-19, according to a presenter at The Liver Meeting Digital Experience.

In this video, Jeffrey A. Sparks, MD, MMSc, associate physician at Brigham and Women's Hospital, explained findings from a study exploring metabolic issues and rheumatoid arthritis.

Researchers observed a significantly increased risk for mortality, mechanical ventilation, ICU admission and 30-day re-admission in patients with COVID-19 with liver disease, according to a presentation at the American College of Gastroenterology virtual annual meeting.

By 2040, researchers predict 75% of cirrhosis cases in North America will be due to nonalcoholic fatty liver disease with a nearly 350% increase in women born after 1980, according to a presenter at the Digital International Liver Conference.

The American Gastroenterological Association released guidance on consultative management of COVID-19 among patients with gastrointestinal and liver manifestations.

Voluntary liver stiffness screening via onsite ultrasound during the Minnesota State Fair yielded high prevalence of liver disease among people previously unaware of any liver disease while 1 month follow-up showed a 70% change of lifestyle in those presenting at high risk, according to data out of Digestive Disease Week.

First responders and those who worked at the site of the September 11 attacks on the World Trade Centers in New York City showed a prevalence of fatty liver at a four times greater occurrence than the general population, according to an expert presenting data during a press conference in advance of Digestive Diseases Week data publication.

A large study of drinking habits in the oncology population revealed high rates of alcohol consumption among patients with and survivors of cancer.

The American College of Gastroenterology released a new guideline on disorders of the mesenteric, portal, and hepatic veins and mesenteric and hepatic arteries, which can lead to acute liver failure, chronic liver disease, noncirrhotic portal hypertension, cirrhosis, and hepatocellular carcinoma.